Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT Trial
Journal and Affiliations:
JACC Cardiovascular Interventions, 10 aprile 2023
Antonio Landi, Cardiocentro Ticino, EOC, USI, Lugano
Enrico Frigoli, Cardiocentro Ticino, EOC, USI, Lugano
Marco Valgimigli, Cardiocentro Ticino, EOC, USI, Lugano e Facoltà di Scienze biomediche, USI, Lugano
Tags:
antiplatelet therapy
dual antiplatelet therapy
high bleeding risk
percutaneous coronary intervention
Authors:
Antonio Landi
Enrico Frigoli
Marco Valgimigli